Cedric Francois - Chief Executive Officer, Director at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
APLS on Nasdaq
All Insider Reports
All Insider Reports

Cedric Francois - trading volume in the past year for Apellis Pharmaceuticals, Inc.

Holdings reported by Cedric Francois for Apellis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 472,065 $13,184,775 $27.93 27 Aug 2025 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023)
Common Stock 331,605 $9,261,727 $27.93 27 Aug 2025 Direct
Common Stock 307,946 $8,742,586 $28.39 28 Aug 2025 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023 - 2)
Common Stock 300,000 $8,379,000 $27.93 27 Aug 2025 Indirect Owner (The Francois Grossi Trust)
Common Stock 234,411 $6,547,099 $27.93 27 Aug 2025 Indirect Owner (The Francois-DuBois Educational Trust)
Stock Option (Right to Buy) 100,538 $5,574,625 $19.39 17 Jul 2025 Direct Common Stock

Transactions reported by Cedric Francois for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.